NCT06427824 Comprehensive Geriatric Assessment (Tests) for Bladder Cancer Participants Undergoing Radical Cystectomy
| NCT ID | NCT06427824 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Bladder Cancer |
| Study Type | INTERVENTIONAL |
| Enrollment | 85 participants |
| Start Date | 2024-08-09 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 85 participants in total. It began in 2024-08-09 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study focuses on providing an educational program for people/participants with bladder cancer who plan to have a cystectomy (surgery) as part of their standard care. Participants in this study will watch videos designed to teach them strategies to help lower their risk of experiencing negative side effects (such as mobility problems, issues with taking medication, and poor quality of life) before and after they have surgery. They will also be asked to fill out questionnaires.
Eligibility Criteria
Inclusion Criteria * Participants capable of giving consent * Participants undergoing radical cystectomy (both for curative and palliative intent) for bladder cancer diagnosed by tissue pathology with urinary diversion at the University of Chicago * Participants undergoing neoadjuvant chemotherapy will be included * Participants will be included regardless of gender, race or ethnicity * Participants greater than or equal to 65 years of age Exclusion Criteria * Radical cystectomy for non-oncologic indications * Palliative cystectomy for cancers other than bladder cancer (i.e. prostate, rectal, cervical)
Contact & Investigator
Piyush Agarwal
PRINCIPAL INVESTIGATOR
University of Chicago
Frequently Asked Questions
Who can join the NCT06427824 clinical trial?
This trial is open to participants of all sexes, aged 65 Years or older, studying Bladder Cancer. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06427824 currently recruiting?
Yes, NCT06427824 is actively recruiting participants. Contact the research team at cancerclinicaltrials@bsd.uchicago.edu for enrollment information.
Where is the NCT06427824 trial being conducted?
This trial is being conducted at Chicago, United States.
Who is sponsoring the NCT06427824 clinical trial?
NCT06427824 is sponsored by University of Chicago. The principal investigator is Piyush Agarwal at University of Chicago. The trial plans to enroll 85 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.